Member Info for Benharper

We do indeed wait for P2 in the autumn, but do you think the newly appointed CBO will also be waiting for P2 before cutting some deals for access to the validated platform?

This looks to be the company William Bachovchin founded to move forward ava3996 and 6000. I presume he then realised the work needed to push them though all the preclinical and clinical work and decided to license it to Avacta.

No Derek my point is that many of the ADC deals going through for huge sums of money are for sales way in the future . 2026 is near term in the Pharma world. Listen to Novartis CEO talking yesterday, they plan over decades not weeks and months. Get it?

Derek, when do expect all these ADC therapies to become standard of care? You are just showing how naive you are.

Https://www.fiercebiotech.com/biotech/jpm24-lilly-ceo-david-ricks-biotechs-were-open-business

This article suggests slightly different. For a platform or pipeline, price tag isn’t an issue

You’ve told us your opinion several times Eggy. Again leave us idiots to it and we’ll see you then.

Donkey, I’d have thought they might have signed an agreement not to talk to media during the trial or their ongoing treatment, I’m sure they wouldn’t want to jeopardise their on going Chemo by doing so. It’ll come, it’s just a matter of patience and enrolling more patients

Exactly Ice, patients in C4 and 5 that continue to have stable disease or tumour shrinkage will now be going way past where their life expectancy would have been on dox. C6 and c7 will be heading that way, with hope

Ashes were in the summer Richar

Spot on Eggy exactly that, now you might as well turn off and come back then, leave us idiots to it.

Where are you hearing that Hurst?

Spot on Timster, it could be our last Christmas, on this board anyway…

No hard feelings Thompi, since then I’ve really enjoyed watching Ophidians relevance in the conversation diminish, with his toys frequently flying out the pram in all directions. His recent deification of Hurst and the riddles have been particularly amusing.

Hi Mark, I did nothing more than tell him to stop being so obnoxious, but the manner by which myself and a couple of others copped it rather than him, showed Alberts colours. It’s no skin off my nose and I only mention it as it showed a distinct biased selection process to the group which raised my suspicions somewhat. I do appreciate your updates from the group and your email contacts with AS though, thanks.

Well I lost all respect for Albert and the group when I was chucked out for Ophidian being obnoxious to me

Top slicing, underwater? Sounds like Heston Blumenthal making pickled onions to me Derek

Avacta may not be presenting at the JP morgan conference but it won’t stop them being part of the conversation there

I was thinking the ‘very large tumour shrinkage’ was likely to be from C5 Jive, so my fingers are crossed for further patients responding very well in C6 and indications of C7 patients heading in the same direction, this would be dynamite for them and fireworks for us

Probably best sell up , nothing happening here. He1 is looking cheap

Doesn’t look like you’ll be getting an Mtd though Lda